研究单位：[1]Allife Medical Science and Technology Co.,Ltd.[2]The First People's Hospital of Yunnan Province/First People's Hospital of Yunan Provinve New Kunhua Hospital[3]Henan Provincial People's Hospital[4]Beijing Hospital
研究目的：
This is a single center, single arm and open-label study to investigate the safety and efficacy of iPS-NCS with Parkinson's Disease
